CLOUDBREAK THERAPEUTICS
Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based upon VIC + 505b(2). We repurpose approved systemic drugs for ocular delivery to treat eye diseases and quickly advance drug candidates to complete proof-of-concept (POC) Phase II clinical trials and to out-license global rights for Phase III clinical trials, product registration, and commercialization. Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CRO) for non-clinical, CMC and clinical development to efficiently maximize capital for drug development.
CLOUDBREAK THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2015-09-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.cloudbreaktherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
171.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Rain Therapeutics
Rain Therapeutics is a operator of a clinical stage biotechnology company.
Current Employees Featured
Founder
Investors List
EFung Capital
EFung Capital investment in Series C - Cloudbreak Therapeutics
Industrial Securities Capital
Industrial Securities Capital investment in Series C - Cloudbreak Therapeutics
Grand Pharmaceutical
Grand Pharmaceutical investment in Series C - Cloudbreak Therapeutics
CDF-Capital
CDF-Capital investment in Series C - Cloudbreak Therapeutics
CDH Investments
CDH Investments investment in Series C - Cloudbreak Therapeutics
Yuejun Investment
Yuejun Investment investment in Series C - Cloudbreak Therapeutics
Dyee Capital
Dyee Capital investment in Series C - Cloudbreak Therapeutics
Yingke Capital
Yingke Capital investment in Series C - Cloudbreak Therapeutics
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series C - Cloudbreak Therapeutics
CCB International
CCB International investment in Series C - Cloudbreak Therapeutics
Official Site Inspections
http://www.cloudbreaktherapeutics.com
- Host name: 217.70.196.104.bc.googleusercontent.com
- IP address: 104.196.70.217
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Cloudbreak Therapeutics"
Cloudbreak Therapeutics - Crunchbase Company โฆ
Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient โฆSee details»
Cloudbreak Therapeutics - Overview, News & Similar companies
View Cloudbreak Therapeutics (www.cloudbreaktherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as โฆSee details»
Cloudbreak Therapeutics Company Profile | Management and
Find contact information for Cloudbreak Therapeutics. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Cloudbreak Therapeutics's email format.See details»
Cloudbreak Pharma - The Org
Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based โฆSee details»
CLOUDBREAK THERAPEUTICS LLC - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and โฆSee details»
Cloudbreak Pharmaceutical 2025 Company Profile: โฆ
Information on stock, financials, earnings, subsidiaries, investors, and executives for Cloudbreak Pharmaceutical. Use the PitchBook Platform to explore the full profile.See details»
Cloudbreak Pharma Information - RocketReach
Cloudbreak Pharma is a Biotechnology, Manufacturing General, and Manufacturing company_reader located in Irvine, California with $4 million in revenue and 15 employees. โฆSee details»
About - Cloudbreak Pharma ๆจๅบท่งไบ
Learn about Cloudbreak Pharma's commitment to revolutionizing eye care with advanced drug therapies for chronic ocular conditions as well as its missionSee details»
CLOUDBREAK THERAPEUTICS LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CLOUDBREAK THERAPEUTICS LLC of Irvine, CA. Get the latest business insights from Dun โฆSee details»
Organization | Cloudbreak Therapeutics, LLC
Cloudbreak Therapeutics, LLC Report issue For profit Phase 2 Phase 3 Founded: Irvine CA United States (2015) Status: No NME R&D (2015) Organization Overview First Clinical Trial โฆSee details»
Cloudbreak Therapeutics - Executive Bio, Top Executies, and โฆ
Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based โฆSee details»
Technology - Cloudbreak Pharma
Partnerships Cloudbreak Therapeutics seeks out licensing opportunity for Phase III ready drug candidates (CBT-001) which is a disease-modifying, first-in-class and the first drug therapy to โฆSee details»
Van Dinh - Co-founder, Chief Operating Officer - Crunchbase
Van Dinh is the co-founder and Chief Operating Officer of Cloudbreak Therapeutics. He has more than twenty yearsโ โexperience in the pharmaceutical industry.See details»
CLOUDBREAK THERAPEUTICS LLC | VentureRadar
Cloudbreak Therapeutics specializes in the development of innovative drug therapies to treat both anterior segment (front of eye) and posterior segment (back of eye) ophthalmic diseases. We โฆSee details»
Cloudbreak Pharma - Crunchbase Company Profile & Funding
Cloudbreak Pharma is a clinical-stage biotechnology company developing ophthalmic drugs for chronic eye diseases.See details»
Cloudbreak Pharma Files for Hong Kong IPO with Focus on โฆ
Jun 6, 2024 Cloudbreak Pharma Inc., a Cayman Islands-registered pharmaceutical company, has filed for an initial public offering (IPO) on the Hong Kong Stock Exchange, with key details โฆSee details»
CBT-006 - Drug Targets, Indications, Patents - Synapse
CBT-006: a Cholesterol modulators Drug, Initially developed by Cloudbreak Therapeutics LLC, Now, its global highest R&D status is Phase 2, Mechanism: Cholesterol modulators, โฆSee details»
Van Dinh - Cloudbreak Pharma
Van Dinh, MBA Co-founder, Chief Operating Officer Van Dinh is the co-founder and Chief Operating Officer of Cloudbreak Pharma. Mr. Dinh has over twenty seven years of experience โฆSee details»
CBT-001 - Cloudbreak Pharma
Cloudbreak Therapeutics CBT-001 | Our Phase III ready drug candidate, CBT-001, would be the first drug therapy to treat pterygium.Surgery may not be the only option for pterygium patients! โฆSee details»
Technology - Cloudbreak Pharma
Cloudbreak Therapeutics specializes in the development of innovative drug therapies to treat both anterior segment (front of eye) and posterior segment (back of eye) ophthalmic diseases. We โฆSee details»